Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-355-3 | CAS number: 15318-45-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Toxicity to reproduction: other studies
Description of key information
Reproductive effects on Rat
TDLo - ROUTE: intraperitoneal; DOSE: 400 mg/kg DURATION: female 1-7D of pregnancy; [Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- (21,431,1970)]
TOXIC EFFECTS:
Effects on Fertility - Post-implantation mortality (e.g., dead and or resorbed implants per total number of implants)
Effects on Fertility - Litter size (e.g., # fetuses per litter, measured before birth)
TDLo - ROUTE: oral; DOSE: 300 mg/kg DURATION: female 9-14D of pregnancy; [Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- (7,41,1973)]
TOXIC EFFECTS:
Effects on Fertility - Post-implantation mortality (e.g., dead and or resorbed implants per total number of implants)
Effects on Embryo or Fetus - Fetotoxicity (except death, e.g., stunted fetus)
Effects on Embryo or Fetus - Fetal death
TDLo - ROUTE: oral; DOSE: 150 mg/kg DURATION: female 9-14D of pregnancy;
[Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- (7,41,1973)]
TOXIC EFFECTS:
Specific Developmental Abnormalities - Musculoskeletal system
TDLo - ROUTE: subcutaneous; DOSE: 400 mg/kg DURATION: female 10-11D of pregnancy; [Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- (18,93,1978)]
TOXIC EFFECTS:
Effects on Embryo or Fetus - Other effects to embryo
TDLo - ROUTE: unreported; DOSE: 250 mg/kg DURATION: female 10-11D of pregnancy; [Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.272- 1972- (293(Suppl),R60,1976)]
TOXIC EFFECTS:
Effects on Embryo or Fetus - Fetal death
Reproductive effects on Mouse
TDLo - ROUTE: oral; DOSE: 2400 mg/kg DURATION: female 7-12D of pregnancy; [Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- (7,41,1973)]
TOXIC EFFECTS:
Effects on Embryo or Fetus - Fetotoxicity (except death, e.g., stunted fetus)
Specific Developmental Abnormalities - Musculoskeletal system
TDLo - ROUTE: oral; DOSE: 6 gm/kg DURATION: female 7-12D of pregnancy; [Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- (7,41,1973)]
TOXIC EFFECTS:
Effects on Fertility - Post-implantation mortality (e.g., dead and or resorbed implants per total number of implants)
Effects on Embryo or Fetus - Fetal death
Source: RTECS Number AB6680000
No epidemiological studies of congenital anomalies in children born to women who took thiamphenicol during pregnancy have been reported.
In one series of studies, the frequency of congenital anomalies was no greater than expected among the offspring of mice or rats treated during pregnancy with thiamphenicol in doses, respectively, 1-33 and 1-3 times those used clinically (Suzuki et al., 1973a, b). Fetal loss occurred at the higher doses which were toxic to the mothers. In contrast, an increased frequency of skeletal malformations was reported among the offspring of rats treated with 2 times the usual human dose of thiamphenicol very early in pregnancy in another study (Silva & Andrade, 1970).
Key References:
Silva NOG, Andrade ATL: The effects of thiophenicol upon the rat conceptus. Fertil Steril 21(5):431-433, 1970. [A]
Suzuki Y, Kondo S, Okada F, Suzuki I, Asano F, Matsuo M, Chiba T: [Effects of thiamphenicol administered to the pregnant animals upon the development of their fetuses and neonates.]
Oyo Yakuri (Pharmacometrics) 7(1):41-51, 1973a. [A]
Suzuki Y, Okada F, Kondo S, Suzuki I, Asano F, Matuo M, Chiba T: [Effects of thiamphenicol glycinate hydrochloride administered to the pregnant animals upon the development of their
fetuses and neonates.] Oyo Yakuri (Pharmacometrics) 7(5):859-870, 1973b. [A]
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
